How CagriSema and tirzepatide compare to other weight loss peptides The obesity treatment landscape extends well beyond these two options
Encouraged by these results, Sekhar has continued his investigations by testing the value of GlyNAC supplementation for improving the health of the growing older population, and has completed an open label trial, and another NIH-funded, double-blind, placebo-controlled trial in older adults
While cardiovascular exercise is important for heart health, excessive cardio can contribute to muscle loss
I think most of us who do this work in pediatrics are, instead of just treating pediatric obesitywere really treating life-course obesity, he said
Comprehensive informed consent
Persistent reactions beyond 72 hours may suggest immune sensitization or contamination and warrant discontinuation